ExLibris header image
SFX Logo
Title: T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management
Source:

Scientific Reports [2045-2322] Ponchel, Frederique yr:2020


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "AB0916-PARE KNOWLEDGE OF DISEASE, DIAGNOSIS, ADHERENCE AND IMPACT OF RESEARCH IN PATIENTS WITH INFLAMMATORY ARTHRITIS." Annals of the rheumatic diseases. 80.Suppl 1: 1479-1480. Link to SFX for this item
2. Burmester, Gerd R. "Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial." Lancet (British edition) 396.10246 (2020): 267-276. Link to SFX for this item
3. "Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST” (Taper Or Abrupt Steroid STop) multicenter trial." PloS one. 18.4. Link to SFX for this item
4. "The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients." Advances in rheumatology. 61.1: 50-. Link to SFX for this item
5. "SP0011 Long-Term Glucocorticoid Use and The Skin." Annals of the rheumatic diseases. 75.s2: 4-5. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced